A Phase I Study of TS-142 in Healthy Participants (Repeated Doses)

A Phase I Study of TS-142 in Non-Elderly Healthy Participants (Repeated Doses) (A Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TS-142 in Non-Elderly Participants)

The purpose of this study is to investigate the safety, pharmacokinetics, and pharmacodynamics of repeated dosing of TS-142 when administered once daily to healthy Japanese non-elderly participants.

Inclusion Criteria:

• Body mass index (BMI) ≥18.5 and <25.0 kg/m^2 at screening inspection

Exclusion Criteria:

• History of clinically relevant disease of some organ systems that may be considerd inappropriately for this study
• History of drug and food allergy